Canada’s decision to legalize the recreational use of cannabis has allowed the rise of an emerging investment market. The cannabis public sector has become one of the most followed industries for investors. 

As such, the Investing News Network brings investors a collection of stories on the critical transition and its impact on the public markets.

A lot of predictions have been made for how exactly the market will react to the legalization of adult-use cannabis and where the money will be moving.

A massive sell-off has gained steam as the popular prediction for what investors are thinking as the Canadian market is set to enjoy a boost from interest all around the world.

The Investing News Network (INN) asked a round of experts for their opinions on whether the sentiment is moving towards buying, selling or holding these pot stocks.

Charles Taerk, president and CEO of Faircourt Asset Management

Taerk, who also acts as a sub-advisor to the Ninepoint Alternative Health Fund, told INN the market has had investors getting cold feet regularly and selling early. He predicted this again could happen the month after legalization.

The executive said he views those selling times as an opportunity for their fund to add for a long term play.

“We’re long term focussed and we use any opportunity for weakness as a buying opportunity. We see this market as a growth story for the next five to 10 years, so our focus is on those companies that are going to be producing successfully over a long period of time,” Taerk said.

Taerk expressed concern for the breakdown of companies able to meet the demands of supply agreements with provinces.

He expects some companies to incur the services of fellow licensed producers (LPs) to purchase additional product.

“Which means that their costs of production are higher than others and this is where we are starting to see a real separation with those companies that do have inventory and do have efficient production are gonna start to move to the fore,” Taerk said.

It’s going to increasingly become a discussion about earnings, so there is going to be a lot of separation we see in the next four to six months.”

Like his fund, Taerk sees the cannabis play as a long term one with plenty of catalysts still to come for the space.

Everett Knight, portfolio manager with Matco Financial

Knight said he expects to see a lot of retail money selling on legalization day on Wednesday (October 17). The manager cautioned investors need to remember, despite the rush and excitement, this is still an emerging market early in its process.

“Just like any industry, we see companies that are overvalued and lots of companies that are still undervalued,” Knight said. “Cannabis investors will have to become more sophisticated and not paint the whole industry with same brush to make better returns.”

Knight said most of the questions he’s getting from potential investors in the cannabis space is whether or not they have missed out.

“My answer is a definite no! However, investors have to be careful of just buying a handful of the highest valued names in the space,” Knight said.

He expects the next three quarters to deliver the results investors need in order to start separating meaningful revenue in the space.

Knight is also concerned about how much actual cannabis will be available for the legal market.

A new joint report from the University of Waterloo and the C.D. Howe Institute shows the supply of cannabis in Canada will reach 210,000 kilograms in the first year of legalization, well short of the estimated demand of 610,000 kilograms the data puts forward.

“People aren’t paying enough attention to the undersupply in the industry day one. LPs are already behind on their provincial contracts and it is far worse than we expected,” Knight said.

Greg Taylor, portfolio manager with Purpose Investments

Taylor also acts as the active manager of the Purpose Marijuana Opportunities Fund (NEO:MJJ). His fund has found success in the pockets of volatility through its active management.

When asked about the potential for a rush come legalization, Taylor said he viewed the blitz following Constellation Brands’ (NYSE:STZ) second investment deal into Canopy Growth (NYSE:CGC,TSX:WEED) as that euphoric move.

“That’s what really woke up the US retail investors… I think that last move we had in September was all US retail and some global investors coming in,” Taylor said.

It almost feels like we got that euphoric move already, it almost feels like [October] 17th is going to be more of a non-event.”

Taylor expressed concern for how much attention the legalization effect will get on day one by way of showing lines of people eager to buy product, since Ontario, arguably the biggest Canadian cannabis market, will have no physical retail shops until 2019.

“I think we can see another wind of excitement come once we can actually start to get some numbers and figure out who actually is making some money,” Taylor said.

Mark Noble, senior vice president of exchange traded fund (ETF) strategy with Horizons ETFs

Noble said investors should get ready for a depression period right after legalization. The ETF executive said investors need to “brace themselves for a little bit of disappointment,” following legalization.

Still, Noble did also express a bullish sentiment for where these stocks are headed.

“What’s occurred is we are betting on potential… within let’s say six to nine months, we’re going to start actually seeing revenues of who’s being successful at selling marijuana to the recreational public. [N]ot everyone is going to be a winner.”

The promise of cannabis companies becoming global players with entries into several markets beyond the adult-use sales is enticing to Noble, who said in the long term those gains could be “exponential.”

Noble suggested the Canada recreational market is already accounted into the price of the stocks, but he sees potential for increases as companies gain options on the global scale.

“Canada is only really round one in the global legalization story and I think where people have not looked to the same degree is in the opportunities that exist outside of Canada,” Noble told INN.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less